Moxifloxacin Infusion

Moxifloxacin 400 mg IV Infusion

Next-Generation Fluoroquinolone for Broad-Spectrum Bacterial Coverage

Moxifloxacin 400 mg Infusion is a powerful 4th-generation fluoroquinolone antibiotic, formulated for intravenous use to provide rapid, broad-spectrum coverage against both gram-positive and gram-negative pathogens, as well as atypical bacteria. It offers excellent tissue penetration and a once-daily dosing convenience, making it ideal for use in hospitals and critical care settings.

Broad-Spectrum Efficacy – Effective against respiratory, intra-abdominal, and skin infections
Once-Daily Dosing – Simplifies administration and improves compliance
Excellent Tissue Penetration – Reaches therapeutic levels in lungs, sinuses, and abdominal tissues
IV to Oral Switch Option – Facilitates seamless transition to oral therapy
Well-Tolerated – Proven safety profile with minimal gastrointestinal or renal impact

Indications:

• Community-acquired pneumonia (CAP)

• Complicated skin and skin structure infections (cSSSI)

• Complicated intra-abdominal infections (cIAI)

• Acute bacterial sinusitis and bronchitis (as per physician’s discretion)

Important Safety Information:
Administer under medical supervision. Avoid in patients with known QT prolongation, CNS disorders, or hypersensitivity to quinolones. Monitor ECG in high-risk patients.

Moxifloxacin 400 mg Infusion
Potent. Precise. Trusted for Serious Infections.